In MPNs, a high number of circulating CD34-positive cells at the time of diagnosis can be used to efficiently distinguish primary myelofibrosis from other MPNs with a threshold of 10 or 15 circulating CD34-positive cells per microliter of peripheral blood [5–7]. The gene discussed is CD34; the disease is myelofibrosis.